Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration

Abstract EN

Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD).

Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes.

VMA in neovascular AMD may induce inflammation, macular traction, decrease in oxygenation, sequestering of vascular endothelial growth factor (VEGF), and other cytokines or may directly stimulate VEGF production.

VMA may also interfere with the treatment effects of anti-VEGF therapy, which is the standard treatment for neovascular AMD, and releasing VMA can improve the treatment response to anti-VEGF treatment in neovascular AMD.

We also reviewed currently available methods of relieving VMA.